Hepion Pharmaceuticals to Present Clinical Data at NASH-TAG Conference
- Oral Presentation Chosen as a “Distinguished” Abstract -EDISON, N.J., Jan. 05, 2022 (GLOBE NEWSWIRE) -- Hepion Pharmaceuticals, Inc. (NASDAQ:HEPA),...
Day: January 5, 2022
Longboard Pharmaceuticals to Present at the H.C. Wainwright BioConnect Virtual Conference
SAN DIEGO, Jan. 05, 2022 (GLOBE NEWSWIRE) -- Longboard Pharmaceuticals, Inc. (Nasdaq: LBPH), a clinical-stage biopharmaceutical company focused on developing...
Clover Doses First Participants with Homologous Booster Dose of COVID-19 Vaccine Candidate in SPECTRA
SPECTRA has been amended to evaluate SCB-2019 (CpG 1018/Alum) as a homologous booster in approximately 4,000 adult participants previously vaccinated...
Bluejay Diagnostics, Inc. Appoints Mark Feinberg, M.D. as Chief Medical Advisor
ACTON, Mass., Jan. 05, 2022 (GLOBE NEWSWIRE) -- Bluejay Diagnostics, Inc. (NASDAQ: BJDX) (“Bluejay”) a late-stage, pre-revenue diagnostics/medical device company...
TRACON Pharmaceuticals to Present at the H.C. Wainwright BIOCONNECT Virtual Conference
SAN DIEGO, Jan. 05, 2022 (GLOBE NEWSWIRE) -- TRACON Pharmaceuticals (NASDAQ: TCON), a clinical stage biopharmaceutical company focused on the...
HEXO Announces the Appointment of a New Board Member and Acting CFO
This news release constitutes a “designated news release” for the purposes of the Company’s prospectus supplement dated May 11, 2021...
Aileron Therapeutics Provides Business Update and Outlines 2022 Strategic Priorities to Deliver Key Milestones
Plans to initiate Phase 1b clinical trial of ALRN-6924 in neoadjuvant breast cancer in 1H22; interim results expected in 4Q22Planned...
Agile Therapeutics to Present at the 40th Annual J.P. Morgan Healthcare Conference
PRINCETON, N.J., Jan. 05, 2022 (GLOBE NEWSWIRE) -- Agile Therapeutics, Inc. (Nasdaq: AGRX), a women's healthcare company, today announced that Chairman...
Elucida Oncology Provides Corporate Update and Outlines Key Upcoming Milestones
Enrolling third dose level in Phase 1/2 dose escalation study of ELU001, our lead clinical program targeting solid tumors overexpressing...
Agile Therapeutics to Present at the Biotech Showcase and H.C. Wainwright BioConnect Virtual Conferences
PRINCETON, N.J., Jan. 05, 2022 (GLOBE NEWSWIRE) -- Agile Therapeutics, Inc. (Nasdaq: AGRX), a women's healthcare company, today announced Chairman and...
Oncotelic Initiates Phase 1 Trial Evaluating CA4P in Combination with Pembrolizumab for Melanoma
AGOURA HILLS, Calif., Jan. 05, 2022 (GLOBE NEWSWIRE) -- Oncotelic Therapeutics, Inc. ("Oncotelic" or the "Company") (OTCQB:OTLC), a leading developer...
Healthcare Integrated Technologies Receives Notice from USPTO Allowing SafeSpace™ Trademark
Trademark approved for “Medical alarm monitoring services for senior living in Class 45” Knoxville, Tennessee, Jan. 05, 2022 (GLOBE NEWSWIRE)...
EDAP Provides Corporate Update on US Focal One Installation Growth
Company announces several key U.S. Focal One installations during Q4 LYON, France, January 5, 2022 -- EDAP TMS SA (Nasdaq:...
Icosavax Appoints Dr. John Shiver to Board of Directors
- Dr. Shiver has contributed to the licensure of 14 pharmaceutical addressing global infectious diseases -SEATTLE, Jan. 05, 2022 (GLOBE...
InflaRx Announces Presentation at J.P. Morgan Healthcare Conference and Other Investor Events
Presentation at J.P. Morgan Healthcare Conference on January 13thCorporate presentation for H.C. Wainwright BioConnect Conference available online starting January 10thCompany...
SalioGen Therapeutics Closes $115 Million Oversubscribed Series B Financing to Advance Gene Coding™ – A New Category of Genetic Medicine
CAMBRIDGE, Mass., Jan. 05, 2022 (GLOBE NEWSWIRE) -- SalioGen Therapeutics, a privately held biotechnology company developing Gene Coding™, a new...
Codexis to Participate in the H.C. Wainwright Virtual BioConnect Conference
REDWOOD CITY, Calif., Jan. 05, 2022 (GLOBE NEWSWIRE) -- Codexis, Inc. (Nasdaq:CDXS), a leading enzyme engineering company enabling the promise...
Entrada Therapeutics Announces the Appointment of Jared Cohen, PhD, JD to General Counsel
BOSTON, Jan. 05, 2022 (GLOBE NEWSWIRE) -- Entrada Therapeutics, Inc. (Nasdaq: TRDA), a biopharmaceutical company aiming to transform the lives...
Surrozen to Present Virtually at the 40th Annual J.P. Morgan Healthcare Conference
Surrozen to provide a business update including discussion of pipeline advancementsSOUTH SAN FRANCISCO, Calif., Jan. 05, 2022 (GLOBE NEWSWIRE) --...
LEXEO Therapeutics to Present at the 40th Annual J.P. Morgan Healthcare Conference
NEW YORK, Jan. 05, 2022 (GLOBE NEWSWIRE) -- LEXEO Therapeutics, a fully integrated clinical-stage gene therapy company advancing adeno-associated virus...
